Scopolamine reversal of tremor produced by low doses of physostigmine in rats: Evidence for a cholinergic mechanism

Neuroscience Letters

Volumn 225, Issue 3, 1997, Pages 157-160

  Stanford, John A ^a   Fowler, Stephen C ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

cholinergic; force; operant; physostigmine; rats; scopolamine; tremor

Indexed keywords

PHYSOSTIGMINE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TREMOR;

ANIMALS; CHOLINERGIC FIBERS; MALE; PHYSOSTIGMINE; RATS; RATS, SPRAGUE-DAWLEY; SCOPOLAMINE; TASK PERFORMANCE AND ANALYSIS; TREMOR;

EID: 0030996289     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00207-3     Document Type: Article

References (16)

1. Aiello-Malmberg, P., Bartolini, A., Bartolini, R. and Galli, A., Effects of morphine, physostigmine and raphe nuclei stimulation on 5-hydroxytryptamine release from the cerebral cortex of the cat, Br. J. Pharmacol., 65 (1979) 547-555.
2. Ambani, L.M. and Van Woert, M.H., Modification of the tremorogenic activity of physostigmine, Br. J. Pharmacol., 46 (1972) 344-347.
3. Brimblecombe, R.W. and Pinder, R.M., Tremors and Tremorogenic Agents, Scientechnica, Bristol, 1972.
4. Fahn, S., Pharmacological differentiation of tremor. In L.J. Findley and R. Capildeo (Eds.), Movement Disorders: Tremor, Oxford University Press, New York, 1984, pp. 85-93.
5. Findley, L.J. and Capildeo, R., Movement Disorders: Tremor, Oxford University Press, New York, 1984.
6. Fowler, S.C., Davison, K.H. and Stanford, J.A., Unlike haloperidol, clozapine slows and dampens rats' forelimb force oscillations and decreases force output in a press-while-licking behavioral task, Psychopharmacology, 116 (1994) 19-25.
7. Fowler, S.C., Liao, R.M. and Skjoldager, P.D., A new rodent model for neuroleptic-induced pseudoparkinsonism: low doses of haloperidol increase forelimb tremor in the rat, Behav. Neurosci., 104 (1990) 449-456.
8. Genovese, R.F., Elsmore, T.F. and Witkin, J.M., Relationship of the behavioral effects of acrophen, atropine, and scopolamine to antagonism of the behavioral effects of physostigmine, Pharmacol. Biochem. Behav., 37 (1990) 117-122.
9. Gothoni, P., Lehtinen, M. and Silen, L., Quantification of tremor in rats induced by physostigmine, Psychopharmacology, 74 (1981) 275-279.
10. Mohanakumar, K.P., Mitra, N. and Ganguly, D.K., Tremorogenesis by physostigmine is unrelated to acetylcholinesterase inhibition: evidence for serotonergic involvement, Neurosci. Lett., 120 (1990) 91-93.
11. Rosecrans, J.A. and Domino, E.F., Comparative effects of physostigmine and neostigmine on acquisition and performance of a conditioned avoidance behavior in the rat, Pharmacol. Biochem. Behav., 2 (1974) 67.
12. Sethy, V.H. and Van Woert, M.H., Antimuscarinic drugs-effect on brain acetylcholine and tremor in rats, Biochem. Pharmacol., 22 (1973) 2685-2691.
13. Sloviter, R.S., Drust, E.G. and Conner, J.D., Specificity of a rat behavioral model for serotonin receptor activation, J. Pharmacol. Exp. Ther., 206 (1978) 339-347.
14. Somani, S.M. and Dube, S.N., In vivo dose response relationship between physostigmine and cholinesterase activity in RBC and tissue of rats, Life Sci., 44 (1989) 1907-1915.
15. Stanford, J.A. and Fowler, S.C., Subchronic effects of clozapine and haloperidol on rats' forelimb force and duration during a press-while-licking task, Psychopharmacology, (1997) in press.
16. Sugimoto, H., Iimura, Y., Yamanishi, Y. and Yamatsu, K., Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperdine hydrochloride and related compounds, J. Med. Chem., 38 (1995) 4821-4829.